Wal-Mart's drug problem: pharmacy business drags on profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Cowen Remains Bullish on Target (TGT) Following Signature Changes
August 20, 2015 8:02 AM EDTCowen maintained an Outperform rating and $90.00 price target on Target (NYSE: TGT) following signature changes. Analyst Oliver Chen views TGT's newness in signature categories, in particular, the strength in home/ apparel is showing structural improvement in traffic trends. Cowen is hosting the... More
